Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tags: HER2


Tiny safety trial prematurely touts ‘clinical benefit’ of cancer vaccine for HER2-positive cancers

1 8/4/2017

Baylor should put the brakes on claims based on a tiny study of breast cancer and extrapolated benefits